We must be so close to preliminary efficacy data being released. Normally with ANP nothing is said until it happens, then Im sure we will see a massive spike in SP. I think given the calibre of the people recently coming on board we know already the data should be promising. Can anyone please provide an estimate of when preliminary data is typically released for open label trials? we are coming on to 28 weeks since first dosing... and no word on EAP yet, sure we are close there too..
Chart, page-336
-
- There are more pages in this discussion • 5,570 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
